Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,911.74
+124.00
(
+3.17%
)
Dow 30
+2.73%
QQQ
+3.56%
VIX
27.23
-1.82
(
-6.27%
)
Kintara Therapeutics Inc
NASDAQ:KTRA
0.29
-0.01
(
-2.36%
)
Products
Kintara Therapeutics Granted Fast Track Designation From The FDA For Val-083 For Newly-Diagnosed Glioblastoma
Published: 06/15/2022 13:15 GMT
KTRA
Kintara Therapeutics Inc (
KTRA
)
- Kintara Therapeutics Granted Fast Track Designation From the FDA for Val-083 for Newly-diagnosed Glioblastoma.
